CADCA Editor 23 de maio de 2016
POSTAGEM NO BLOG

Líderes de Prevenção de Abuso de Substâncias do Missouri se unem para desenvolver estratégias eficazes para lidar com a epidemia de opioides em St. Louis

Summit is Cornerstone of DEA’s 360 Strategy

O QUE:           More than 100 substance abuse prevention leaders from across Missouri will gather at Cúpula CADCA: Uma Abordagem Abrangente para Enfrentar as Pílulas para a Epidemia da Heroína. The summit, hosted by CADCA (Community Anti-Drug Coalitions of America) and in partnership with the Drug Enforcement Administration (DEA), will provide substance abuse prevention specialists with an overview of the national and local prescription drug and heroin abuse problem and explore the associated public health issues of overdose. The focus of the hands-on summit is for attendees to develop effective strategies to address the epidemic in their communities utilizing tactics aimed at changing or influencing community conditions, standards and regulations, and institutions and policies.

 

QUANDO:          May 24, 2016 from 9 a.m. – 4:30 p.m.

 

ONDE:        St. Louis College of Pharmacy

                     4588 Parkview Pl., Room ARB 212

                     St. Louis, Mo. 63110

 

EXPERTS AVAILABLE FOR INTERVIEWS:   

           

  • Gen. Arthur T. Dean, Chairman & CEO, CADCA
  • James P. Shroba, Special Agent in Charge, St. Louis Division, DEA    
  • Juan Wilson, Task Force Officer, St. Louis Division, DEA
  • Chuck Daugherty, Executive Director, ACT Missouri
  • Howard Weissman, Executive Director, NCADA
  • Local substance abuse prevention coalition leaders                   

About DEA 360 Strategy

The DEA 360 Strategy takes an innovative three-pronged approach to combating prescription opioid and heroin abuse through: (1) coordinated law enforcement actions against drug cartels and heroin traffickers in specific communities; (2) Diversion Control enforcement actions against DEA registrants operating outside the law and long-term engagement with pharmaceutical drug manufacturers, wholesalers, pharmacies, and practitioners; and (3) community outreach through local partnerships that empower communities to take back affected neighborhoods after enforcement actions and prevent the same problems from cropping up again.

 

Navegue pelo nosso blog